537578's Discussions - Simply Wall St

Dashboard Portfolios Watchlist Community Discover Screener

53

537578

Member since 2025

Views

1.2k Total number of views

Fair Values Set

16 Total number of fair values set

Comments

7 Total number of comments

Followers

1 Total number of followers

No bio added yet

No link added

Narratives Watchlists Portfolios Discussions Likes

RXRX·7 months agoRXRX: FAP Trial Success Will Support Future Margin Expansion Potential

I now believe Recursion Pharmaceuticals will one day be the Palantir of biotechnology! Najat Khan the new CEO will lead RXRX to greatness! Once REC-4881 is approved by the FDA the sky’s the limit! Former CEO is gone and that’s a good thing! He stepped down finally!!

0

|

0

RXRX·7 months agoRXRX: Positive FAP Trial Data Will Support Stronger Long Term Thesis

Thank god the former CEO is gone! Maybe all these insiders should go! All they do is sell their shares! Perhaps they’re the shorts like some people are saying!!

0

|

0

RXRX·7 months agoRXRX: Positive FAP Trial Results Will Support Future Margin Expansion

RXRX will be a winner with Najat Khan! With her leadership recursion pharmaceuticals will one day be the next Palantir in biotechnology!!!

0

|

0

RXRX·8 months agoRXRX: New CEO Appointment Will Spark Stronger Margins And AI-Driven Momentum

Regarding FAP JP Morgan said there’s a 60% chance REC-4881 will be approved and will generate $1,000,000,000! They also say 50,000 people in the world have FAP! Others say the population of FAP will be around 100,000 and if this is the case you’ll see a revenue EXPLOSION of $2,000,000,000!!!

0

|

0

RXRX·8 months agoRXRX: New CEO Appointment Will Spark Stronger Margins And AI-Driven Momentum

The FDA will approve REC-4881 within 18 months! When this happens everything falls into place! Najat Khan is a GENIUS! RXRX will one day be the Palantir of biotechnology!

0

|

0

RXRX·9 months agoRXRX: Positive TUPELO Data Will Drive Future AI-Enabled Margin Expansion

Thank God the old CEO is stepping down! Continues to unload massive amounts of shares! This tells us he’s not a very confident leader according to many people! He needs to go! Did absolutely nothing but drive RXRX from $40 a share to below $4 according to many people! A true leader with experience , expertise and integrity will take over as CEO on January 1. She will lead RXRX into greatness once again! Congratulations Najat Khan now reach for the moon 🌖!!!

0

|

1

RXRX·9 months agoRXRX: New CEO Appointment Will Spark Stronger Margins And AI-Driven Momentum

Najat Khan will lead RXRX to greatness! With her experience and expertise in biotechnology RXRX will have a banner year in 2026!

0

|

0

Make Better Investing Decisions Anywhere

Scan to download

Open AppStore Open Google Play

Chrome Web Store

Level 5, 320 Pitt Street, Sydney

Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.

View Data Sources

Markets

US: NYSE & NASDAQ
UK: FTSE
Australia: ASX
India: NIFTY
Canada: TSX
South Africa: JSE
Japan: NIKKEI
South Korea: KOSPI
Germany: DAX

Investing Ideas

Undervalued Companies
Dividend Powerhouses
Insider Buying
Nuclear Energy
Autonomous Vehicles
Artificial Intelligence
Crypto and Blockchain
Cybersecurity
More ideas

Stock Communities

AstraZeneca
HSBC Holdings
Shell
Unilever
Diageo
Rio Tinto Group
RELX
BP
Barclays

Features & Tools

Portfolio Tracker
Stock Screener & Alerts
Narratives & Fair Values
Dividend Calculator

News & Discovery

Latest Stock News
Global Market Insights
The Foxhole
Investing Ideas
Community Narratives
What's New

Simply Wall St

Plans & Pricing
Advertising
About Us
Contact Us
Careers

Help Center
Learn Stock Investing
Affiliate Program
Business & Enterprise
Charlie AI

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206

Terms and Conditions
Privacy Policy
AI Terms
Financial Services Guide